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Iron depletion in blood donors has been a topic of concern for the AABB over the
past couple of years. In March 2017 the AABB published bulletin #17-02 recommending
blood collection facilities implement additional actions to limit or prevent iron deficiency
in blood donors. Three of the recommended strategies were to limit the donation interval
for all individuals to two times in a 12-month period, limit 16–18 year olds to one
donation in a 12-month period, and to limit pre-menopausal woman to one donation in a
twelve month period. With a declining donor pool, the focus of this study is on
additional effects of implementing the three aforementioned strategies on the blood
supply of a southeastern community blood collection facility. My findings suggest that if
any of the three donation interval changes were implemented, there would be additional
reductions in the blood supply.
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INTRODUCTION
Background
One of the physical screening practices required for donating blood in the United
Sates is the measurement of hemoglobin or hematocrit prior to phlebotomy. A male
donor is considered eligible if he has hemoglobin ≥ 13.0 g/dL or a hematocrit ≥ 39%. A
female donor is considered eligible if she has hemoglobin ≥ 12.5 g/dL or a hematocrit ≥
38% (Fung, 2017). During the donation process, a donor loses approximately 500 ml of
blood volume, containing an estimate of 200–250 mg of iron (Bialkowski et al., 2015).
Despite the current practices of hemoglobin/hematocrit screening to protect the health of
blood donors, one of the consequences of blood donation is iron depletion.
The recommendations from the AABB, in its published bulletin #17-02 on March
16, 2017, requested that blood collection establishments take additional voluntary actions
to monitor, limit, or prevent iron deficiency in blood donors (Szczepeorkowski &
Hopkins, 2017). Currently, the stipulations in the 30th edition of the Standards for Blood
Banks and Transfusion Services only require donor centers to provide blood donors with
education materials, which includes the risks of post donation iron deficiency that can be
found in standard 5.2.1.5. (Ooley, 2016). The donors only need to acknowledge that they
have received the materials with signature. Ooley (2016) outlines three additional iron
mitigation recommendations along with strategies and interventions. The bulletin
includes recommendations that blood establishments voluntarily implement one of the
following strategies:
1.   Development of a program to provide replacement iron in absence of
ferritin measurements.
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2.   Measurement of serum or plasma ferritin.
3.   Evidence-based lengthening of donation interval, or restrict number of
donations per year.
Under strategy number three, the lengthening interval and/or decreasing the
number of donations per year provides three additional options. Option one limits whole
blood donations to two times in a 12-month period, or one 2-unit collection in 12-month
period. Option two limits the number of whole blood collections from 16–18 year olds to
one time in a 12-month period because of the higher documented rates of iron deficiency
in young donors. Option three limits whole blood collections from premenopausal
women to one donation in a 12-month period (Szczepeorkowski & Hopkins, 2017).
Throughout history, physicians have used blood and its components to treat a
variety of ailments ranging from blood loss to autoimmune diseases. The first recorded
blood transfusion occurred in England in 1665 between two dogs, but it was not until
1818 that a successful human blood transfusion occurred. In 1914, Adolf Hustin
discovered that sodium citrate could be used as an anticoagulant and could be stored for
transfusions for patients on the battlefield. This led to the first blood bank established at
a Leningrad hospital in Russia in 1932. Eight years later, the United States established a
nationwide blood collection program, and in 1970, the collection program became an allvolunteer donor base. In 1949, the total United States blood collection system consisted
of 1,500 hospital blood banks, 46 community blood centers, and 31 American Red Cross
regional blood centers. Through consolidation currently there are approximately 67
community blood centers in the United States including the Southeast Community Blood
Center (pseudonym) whose data was used for this research project.
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National Data
The United States has a volunteer-based donation program comprised of
community- and hospital-based blood collection centers. Their mission is to collect,
process, and distribute blood and blood products. For the purpose of this study, the blood
product I will focus on is red blood cells processed from whole blood donors. It is
imperative that our national blood supply meet the needs of the hospitals routine and
emergency requests.
In 2003, the Office of the Assistant Secretary for Health developed a National
Blood Collection and Utilization Survey (NCBUS) administered by the Centers for
Disease Control and Prevention (CDC) and the AABB (Ellingson, 2017). Since 2011,
the NCBUS has identified a continuous decline in red cell collections and utilization.
Data from the 2015 NCBUS indicates an 11.2% decrease in allogeneic non-directed
whole blood collections from 2013. Figure 1 illustrates how the gap between collections
and transfusions per 1000 population continues to narrow. Data shows 60.4 collections
per 1000 collected, compared to 35.3 per 1000 units transfused. The NCBUS data also
identified a 14.3% national blood collection deferral rate with almost half due to low
hemoglobin.
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Figure 1. RBC Collections Compared to Transfusions

Source: Ellingson, K., Sapiano, M., Haass, K., Savinkina, A., et al. (2017). Collection
Transfusion Graph. National Blood Collection and Utilization Survey Report
Local Data
Red blood cells collected by one local blood center in the southeast went from
33,032 units collected in 2015 to 30,208 collected in 2016, which is a decrease of 8.7%.
The organizations deferral rate (donors who were told they could not donate) was 16%
with 9% the result of low hemoglobin.
Problem Statement
It is unclear how each of the AABB strategies for the prevention of iron
deficiency in blood donors may affect the blood supply of an individual local southeast
community blood center.
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Research Question
What is the estimated differential impact on the local blood supply if a
southeastern community blood center implements the AABB recommendation of
lengthening the donor interval, and/or decreasing the number of donations per year.
Research Hypothesis
I expect that the impact of the different strategies will be influenced by a center’s
donor age and sex distribution and by total volume of annual collections.
Study Objective
The study’s objective is to develop and deploy an analytical response to historical
data from a blood center to compare the expected effects of different AABB prevention
strategies on the overall U.S. blood supply.
Population
I extracted de-identified data from a southeastern community blood center’s
central computer system for the population that donated blood for the 2016 calendar year.
The donor population is diverse, consisting of 17,462 donors with a minimum age of 16
years old, a median age of 47 years old with no upper age limit.
Assumption
The data extracted from the Blood Bank Computer System (BBCS) for the 2016
calendar year is adequate for representing donor behavior in future years.
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LITERATURE REVIEW
Chapter Two consists of a review of related research on the relevance of using
hemoglobin/hematocrit screening for qualifying blood donors and how it relates to the
identification of iron deficiency. The chapter will also describe the AABB
recommendations and what researchers have discovered about iron depletion within the
donor population. The review will include the current status of the donor population
along with a review of the sustainability of the blood supply. Ultimately, the aim of this
chapter is to expose and interrogate the reasoning behind the AABB’s recommendations
to lengthen the donor interval, and/or decrease the number of donations per year on the
study site, a local southeastern blood center.
Hemoglobin/Hematocrit Screening
Hemoglobin is a protein found in red blood cells and is a combination of a hem
protein and an iron molecule. The main function of hemoglobin is to carry oxygen from
the lungs to body tissue. Hemoglobin levels less than 12 gm% may indicate the
individual is in a state of anemia (Rudmann, 1995). Iron is stored in the body in the form
of ferritin and circulates in the blood. Ferritin is an important component of the human
body system because it combines with molecules that aid in cellular respiration and
metabolism. Figure 2 represents a hemoglobin molecule found in red blood cells.
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Figure 2. Hemoglobin Molecule

Source: Sylvia M. (1997), Hemoglobin Molecule, Inquiry into Life, 8th edition
A male donor is eligible to donate whole blood if his hemoglobin measurement is
≥ 13.0 g/dL or the hematocrit is ≥ 39%. A female donor is eligible to donate whole blood
if she has a hemoglobin measurement ≥ 12.5 g/dL or the hematocrit is ≥ 38% (Fung,
2014).
The Food and Drug Administration (FDA) allows for the measurement of either
hemoglobin or hematocrit to determine donation eligibility. There is no clinical
difference between the two measurements and allowing both types of test enables blood
centers to choose a method that matches with preferred internal process (Food and Drug
Administration, 2015). When calculating hemotocirit you can you can multiply
hemoglobin by three.
Iron is an important nutrient required for the body to function. The total iron
found in the body is estimated at 3.9 g while 2.5 g is found in hemoglobin. Hemoglobin
thus accounts for approximately 70% of the body’s total iron. The other 30% can be
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found in the heart (500 mg), liver (250 mg), bone marrow (150 mg), muscles, in the form
of myoglobin (300 mg), enzymes in the body (150 mg), and plasma, which carries 5 mg
bound to transferrin protein (Camaschella, 2011). Figure 3 diagrams the uptake of daily
iron within the human body.

Figure 3. Iron Metabolism

Source: Abbaspour N, Hurrell R, Kelishadi R. (2014). Iron Transport System diagram.
Licensed under Open Access Res Med Sci Journal
Iron Deficiency in Blood Donors
The objective of the REDS-II Donor Iron Status Evaluation (RISE) was to
determine the optimal laboratory measures to identify iron deficient erythropoiesis (IDE),
or absent iron stores (AIS) in blood donors and the ability of hemoglobin to identify iron
depletion in presenting donors. Iron deficiency moves through three stages: the first
stage is iron depletion while red cell morphology and hemoglobin levels remain normal;
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second stage is IDE, with the red cell morphology and hemoglobin levels remaining
normal; and the third stage is iron deficiency anemia indicated by abnormal red cell
morphology and a decreased hemoglobin level. Kiss et al. (2013) concluded that red
blood cell indices hypochromic mature RBCs (HYPOm), content of reticulocyte (CHr)
correlate with AIS and IDE better than the hemoglobin measurement, but are not
sensitive or specific enough to be used as a diagnostic test for blood donors.
Studies have shown that blood donation may result in depleted iron stores for
donors with normal pre-donation hemoglobin values. Mobilizing iron stores in the form
of ferritin makes up the iron loss. Men usually have the most dramatic drop in ferritin
levels because of higher iron stores before donation. In one study in Australia,
researchers found that about 19% of female blood donors were iron deficient at a
hemoglobin level of 12.5 g/dL, while about 5% of male donors were iron deficient at a
level of 13.5 g/dL (Lucky et al., 2014).
Up to two-thirds of young women in developing countries suffer from iron
deficiency. However, it is not only a phenomenon of developing nations, with prevalence
rates between 10% and 20% in the United States and Europe. Latent iron deficiency, also
known as IDE, is characterized by individuals having serum ferritin ≤ 20 ng/mL and
hemoglobin > 12 g/dL . Iron-deficiency anemia is the most severe form of iron deficiency
and is characterized by having hemoglobin ≤12 g/dL in addition to having low serum
ferritin (Falkingham et al., 2010).
A study performed by Bialkowski et al. (2016) to analyze strategies to reduce iron
deficiency (STRIDE) demonstrated that providing 19 mg or 38 mg of iron daily or iron
status information (donor brochures) after ferritin testing was effective and mostly
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equivalent in mitigating post-donation iron deficiency. One of the limitations of the
study was that it was randomized, meaning it may not represent the way donors behaved
at community blood centers. A finding of particular interest is that de-enrollment for
donors receiving tablets was higher within 60 days. Reasons for the de-enrollment
included gastrointestinal symptoms and rash formation indicating side effects of taking
iron supplements.
Another study enrolled males and females 18 years old and older from four U.S.
blood donor centers. Donors were separated into two groups based on their ferritin tests
(> 26 ng/mL and less than 26 ng/mL). The subjects either received 37.5 mg of oral
ferrous gluconate for 24 weeks daily or no supplementation. Results indicated that levels
in both the high and low ferritin groups, donors given the iron supplements returned to
80% pre-donation ferritin. The Hemoglobin Iron Recovery Study (HEIRS) also
concluded that donors taking iron supplementation recovered to their baseline in 11
weeks compared to more than 24 weeks for individuals who did not take iron
supplementation (Kiss et al., 2015).
An Australian study analyzed female whole blood donors who were given iron
directly or given advice on taking iron supplements. Eighty-eight percent of the donors
given the iron directly maintained ferritin levels and did not experience a decline. Fortyfour percent of the donors complied with the recommendation but most donors failed to
maintain ferritin levels. The screening process was extended by one to five minutes and
adverse effects were common but mild (Pasricha, Marks, & Salvin, 2017).
Iron supplementation in individuals with normal iron stores has several potentially
harmful side effects and is not recommended. Overload may lead to secondary
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hemochromatosis, increased oxidative stress, and production of free radicals (Nowsheen
et al., 2009). Researchers have shown that oxidative stress plays a role in causing cancer.
When treating for iron deficiency the intention is to “first do no harm” (Zoller & Vogal,
2004).
Restless legs syndrome (RLS) is a neurological sensorimotor disorder and has
been associated with iron deficiency anemia. A Danish blood center enrolled 13,448
blood donors and found that 7.2% woman and 4.5% men were classified with RLS.
Researchers concluded that the disorder was not related to reduced plasma ferritin,
employment status, or income level (Didriksen et al., 2017).
The 30th edition of the Standards for Blood Banks and Transfusion Services
includes reuiquirements that donor centers provide blood donors with educational
materials that includes information about the risks of post-donation iron deficiency,
which can be found in standard 5.2.1.5. (Ooley, 2016). According to recommendations,
patients must acknowledge receipt of this educational information. Figure 4 is an
example of the information form used by Shepeard Community Blood Center.
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Figure 4. Iron Information Handout
The AABB bulletin #17-02, published on March 16, 2017, recommended blood
collection establishments take additional voluntary actions to monitor, limit, or prevent
iron deficiency in blood donors (Szczepeorkowski & Hopkins, 2017). The bulletin
outlines three additional recommendations along with strategies and interventions. Blood
establishments voluntarily should implement one of the following strategies:
1.   Development of a program to provide replacement iron in absence of
ferritin measurements.
2.   Measurement of serum or plasma ferritin.
3.   Evidence-based lengthening of donation interval, or restrict number of
donations per year.
Under strategy number three, the lengthening interval and/or decreasing the
number of donations per year includes three further options. The first limits whole blood
donations to two times in a 12-month period, or one two-unit collection in a 12-month
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period. The second limits whole blood collections from 16–18 year olds to one time a
year in response to higher documented rates of iron deficiency in young donors. The
third limits whole blood collections from pre-menopausal women to one donation in a
12-month period (Szczepeorkowski & Hopkins, 2017).
Donor Population
Riley, Schwei, and McCullough (2007) concluded that the United States’
conventional method for determining donor eligibility was out of date and suggested a
new method. This propsal changed the potential eligible population in the United States
from 60.2% to 37.8%. The new method formula is:
Total eligible donor population = (Total population-Age exclusions) - (Total
population-Age exclusions) x (Adjusted prevalence – overlap adjustment). It is
important to note that the model was lacking additional exclusions such as
vaccinations, recent blood donations (within 8 weeks), transplant, transfusion,
piercing, or certain prescription medications as well as sociologic determinants.
In Australia, Lucky et al. (2014) expanded the 31 donor exclusion factors to 70
factors. Their refined method attempted to predict more accurately the donor-eligible
pool. According to their study, 67% of the population between the ages of 16 and 18 was
excluded from donating blood. Of the 33% of the population eligible to donate blood in
Australia, only about 5.6% donate annually. Accounting for repeat donations, the
calculated number is 12.2 units of blood collected per 100 potential donors.
Whole blood collection and transfusions continue to decline based on the 2015
National Blood Collection and Utilization Survey (NBCUS). The United States collected
12,056,000 whole blood units excluding autologous collections and rejected units, which
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was a decline of 10.2 % from 2013. Red blood cell transfusions also declined 14% from
2013 to 2015, with a 2015 total of 11,330,000. The hospitals outdated 186,000 red blood
cell units and blood centers outdated 414,000 red cell units (Ellingson, 2017).
Blood Supply Sustainability
In 2016, American Blood Centers (ABC) an organization representing all
community blood centers in the Unites States partnered with the U.S. Department of
Health and Human Services (HHS) to fund a study to analyze the United States’ blood
supply and its current sustainability. The study cost approximately $1.2 million and was
performed by the RAND Corporation and released in December of 2016. The
researchers attempted to describe the current system and employed a mixed-method
approach, using available data and interviews with stakeholder groups. The purpose of
the study was to inform federal policymakers about the current environment and the
future regarding blood supply, payment for services, and corporate investment regarding
innovation (RAND Corporation, 2016).
The RAND report had the following recommendations meant to improve the
sustainability of the U. S. blood system (RAND Corporation, 2016, p. xvi–xvii):
1.   Collect data on blood use and financial arrangements – While stakeholders
have access to statistics on blood use and transactions related to their
individual organizations, the U.S. government currently does not have access
to comprehensive data describing the performance of the blood system as a
whole.
2.   Develop and disseminate a vision for appropriate levels of surge capacity –
Describing a desired level or surge capacity from public health and
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preparedness perspective will help stakeholders and policy makers plan and
estimate the costs associated with maintaining surge capacity in the blood
system aside from the usual transaction-based arrangements between blood
centers and hospitals.
3.   Subsidize blood centers’ ability to maintain surge capacity – Surge capacity to
respond to serious events and emergencies falls outside the typical financial
arrangements between hospitals and blood centers. In the current
environment of falling demand for blood and resulting excess supply, centers
have shown some surge capacity to meet emergency needs. However, once
the industry has adjusted to lower demand, there is no guarantee that this
surge capacity will remain. If blood centers are asked to retain excess staff,
collection capabilities, or stock for any reason other than meeting the current
demand for blood from hospitals, there is a strong argument that the
government should separately finance this surge capacity.
4.   Build relationships with brokers and other entities to form a blood “safety net”
– HHS should build ongoing relationships with the American Red Cross
(ARC) the Armed Services Blood Program (ASBP), and brokerage entities
that would commit to procuring and delivering blood at the request of HHS to
address short-term and local shortages. A well-established set of relationships
can reduce response times in the case of shortages.
5.   Build and implement a value framework for new technology – RAND
recommended that HHS invest in health technology assessment research for
existing technologies with low adoption rates and for technologies on the
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horizon. These analyses should distinguish between costs and benefits
accruing to blood centers and hospitals and costs and benefits from the
broader societal perspective. For technologies with significant costs and
benefits from the societal perspective but not from the blood center and
hospital perspective, policy intervention could encourage adoption.
6.   Pay directly for new technologies for which there is no private business case
for adoption – Decisions to adopt some tests that are now industry standards
are difficult to justify from the business perspectives of blood centers and
hospitals. However, these technologies often have clear public health and
preparedness benefits, so policy makers may want to require or at least
encourage adoption. In these cases, U.S. government financing of technology
acquisition costs might be appropriate.
7.   Implement emergency use authorization and contingency planning for key
supplies and inputs – HHS could through the FDA to implement emergency
use authorizations for replacement supplies and other inputs in the event of a
shortage.
Researchers performed a stock and flow simulation at a national and interregional level for a pandemic and a mass casualty emergency event on the blood supply
system. Results indicated that the variables used in the model are highly customizable
and can be manipulated depending on current data and or situation. Simonetti et al.
(2017) discovered that no shortage of blood occurred in either scenario, indicating the
blood system was robust enough if blood is moved from region to region within a
centralized blood transfer system.
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Klein, Hirouda, and Epstein (2017) described the current blood system as being in
danger of a major disruption. As blood usage and collections decline the cost of
producing a unit of red blood cells has increased for the blood center as hospital
reimbursements have declined. The combination of the two resulted in an estimated 90%
of blood centers providing red blood cells below cost. They concluded that “outwardly
the blood-delivery system appears to be functioning effectively but evidence that a oncereliable system is faltering is unmistakable” (p. 1488).
Monte Carlo Simulation
The Monte Carlo method is a technique that approximates solutions to
quantitative data by translating uncertainties in model inputs into uncertainties in model
results. The result of a single simulation represents a qualified statement, but the result of
a Monte Carlo simulation is a quantified probability. The simulation runs a great number
of times and the output results are probability distributions (GoldSim, 2017).
The simulation works by selecting a random value for each task. The model is
calculated based on this random value. The result is displayed and the process is repeated
hundreds or thousands of times depending on the circumstances. When complete, the
results are used to describe the likelihood or probability of reaching various results. The
Environmental Protection Agency (EPA) uses Monte Carlo simulation in risk
assessments but must ensure they include single-point risk estimates prepared under
current EPA guidelines (Smith, 1994).
Summary
Chapter Two provided some insight to the the AABB’s decision to publish
bulletin #17-02. As the research and analysis to potentially protect the blood donor
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continues, the impact on supply of blood in an already declining collection population
must be discussed. The risk of lengthening the donor interval, and/or decreasing the
number of donations per year on the blood supply must be quantified to understand the
true impact of the decision for southeastern community blood centers. After consultation
and review, the Monte Carlo simulation will not provide the essential predictability
matrix; therefore, it should not be used to estimate the reduction in blood collections.

METHODOLGY
Research Design
The research design for this study is a descriptive study using quantitative data
from blood donors who donated whole blood from January 1, 2016–December 31, 2016
at a southeast community blood center. Statistical analysis will be used for each of the
following three options:
1.   Limit whole blood donations to two times in a 12-month period, or one 2-unit
collection in 12-month period .
2.   Limit whole blood collections from 16–18 year olds to one time a year.
3.   Limit whole blood collections from pre-menopausal women to one donation
in a 12-month period.
A reduction in donors will directly correlate to a reduction in the collection of red blood
cells. With the manipulation of some of the variables, the final result would be to
produce a predictability chart that the donor center could use in determining the impact of
the three options based on their data.
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Data Set Description
I gathered data from the Southeast Community Blood Center’s Blood Bank
Computer System database, which contains 17,462 donors for fiscal year 2016. The data
set does not contain names of the donors and was compiled into excel for analysis. The
fixed data fields were separated into the following columns:
1.   donor number
2.   gender
3.   age
4.   birth year
5.   birth month
6.   birth day
7.   blood type
8.   race
9.   Hgb/HCT
10.  number of donations
Using the above data, calculations were made by limiting individuals to donating
only two times in a 12-month period, limiting donors 16–18 years old to donating only
one time in a 12-month period, or limiting pre-menopausal woman to only one donation
in a twelve month period.
Data Analysis
The Statistical Analysis System (SAS) software was used to analyze the data set
for for the three donor interval options:
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For the option of limiting whole blood donations to two times in a 12-month
period, or one 2-unit collection in 12-month period, I will use the following calculation:
% Loss = Total Products – Total Products (removing donor collections > 2
donations in a 12-month period / Total Products x 100.
For the option to limit whole blood collections from 16–18 year olds to one time
in a 12-month period, the calculation is:
% Loss = Total Products – Total Products (removing donor collections > 2 from
16–18 year olds in a 12-month period / Total Products x 100
For option three, limiting whole blood collections from premenopausal women to one
donation in a 12-month period, I will use the calculation:
% Loss = Total Products – Total Products (removing donor collections > 2 from
females < age 50 in a 12-month period / Total Products x 100
Each of the three scenarios will reveal the percentage changed in the number of
red cell units collected.
Limitations
The data extracted was a point in time in the 2016 calendar year and does include
fluctuations that occur year to year based on external factors such as natural disasters,
community health outbreaks, additional mandated testing, and the state of the economy.
Demographics differ from region to region; therefore, other community blood centers’
donor mix of age and gender may not correlate exactly with the Southeast blood center’s
database.
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